Celera Genomics (CRA) Reports Second Quarter Fiscal 2005 Results

ROCKVILLE, Md.--(BUSINESS WIRE)--Jan. 27, 2005--Celera Genomics Group (NYSE:CRA), an Applera Corporation business, today reported a net loss of $19.4 million, or $0.27 per share, for the second quarter of fiscal 2005 ended December 31, 2004, compared to a net loss of $13.6 million, or $0.19 per share, for the second quarter of fiscal 2004. All per share amounts refer to Applera Corporation-Celera Genomics Group Common Stock.

Back to news